Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 8 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors at 4 institutions in 3 countries.
Aneta KaczorDepartment of Technology and Biotechnology of Drugs, Jagiellonian University, Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.
Karolina WitekDepartment of Technology and Biotechnology of Drugs, Jagiellonian University, Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.ORCID 0000-0003-3923-1853
Sabina PodlewskaDepartment of Technology and Biotechnology of Drugs, Jagiellonian University, Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.ORCID 0000-0002-2891-5603
Veronique SinouUMR_MD1, U-1261, Aix Marseille Univ, INSERM, SSA, MCT, Faculté de Pharmacie, 27 Bd Jean Moulin, 13005 Marseille, France.ORCID 0000-0001-9248-3043
Joanna CzekajewskaDepartment of Pharmaceutical Microbiology, Jagiellonian University, Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.ORCID 0000-0001-5936-7761
Ewa ŻesławskaPedagogical University of Cracow, Institute of Biology, ul. Podchorążych 2, 30-084 Krakow, Poland.ORCID 0000-0003-1946-9370
Agata Doroz-PłonkaDepartment of Technology and Biotechnology of Drugs, Jagiellonian University, Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.
Annamaria LubelskaDepartment of Technology and Biotechnology of Drugs, Jagiellonian University, Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.
Gniewomir LataczDepartment of Technology and Biotechnology of Drugs, Jagiellonian University, Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.ORCID 0000-0001-9247-2598
Wojciech NitekFaculty of Chemistry, Jagiellonian University, ul. Gronostajowa 2, 30-387 Krakow, Poland.
Markus BischoffInstitute for Medical Microbiology and Hygiene, Saarland University, D-66421 Homburg/Saar, Germany.
Sandrine AlibertUMR_MD1, U-1261, Aix Marseille Univ, INSERM, SSA, MCT, Faculté de Pharmacie, 27 Bd Jean Moulin, 13005 Marseille, France.ORCID 0000-0001-5811-0139
Jean-Marie PagèsUMR_MD1, U-1261, Aix Marseille Univ, INSERM, SSA, MCT, Faculté de Pharmacie, 27 Bd Jean Moulin, 13005 Marseille, France.ORCID 0000-0001-7092-7977
Claus JacobDivision of Bioorganic Chemistry, School of Pharmacy, Saarland University, Campus B 2.1, D-66123 Saarbruecken, Germany.ORCID 0000-0002-6288-7220
Elżbieta KarczewskaDepartment of Pharmaceutical Microbiology, Jagiellonian University, Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.ORCID 0000-0001-7188-1077
Jean-Michel BollaUMR_MD1, U-1261, Aix Marseille Univ, INSERM, SSA, MCT, Faculté de Pharmacie, 27 Bd Jean Moulin, 13005 Marseille, France.ORCID 0000-0003-3892-4340
Jadwiga HandzlikDepartment of Technology and Biotechnology of Drugs, Jagiellonian University, Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.ORCID 0000-0002-3674-3581
Jagiellonian University · PLInserm · FRSaarland University · DEUniwersytet Komisji Edukacji Narodowej w Krakowie · PL
Funding
Ministerstwo Nauki i Szkolnictwa Wyższego "Diamond Grant" no 0169/DIA/2017/46Uniwersytet Jagielloński Collegium Medicum N42/DBS/000027Uniwersytet Jagielloński Collegium Medicum N42/DBS/000070Uniwersytet Jagielloński Collegium Medicum N42/DBS/000093Uniwersytet Jagielloński Collegium Medicum N42/DBS/000165 and N42/DBS/000162Wydział Lekarski, Uniwersytet Jagielloński Collegium Medicum N42/DBS/000096
6 · The paper itself
Abstract
In the search for an effective strategy to overcome antimicrobial resistance, a series of new morpholine-containing 5-arylideneimidazolones differing within either the amine moiety or at position five of imidazolones was explored as potential antibiotic adjuvants against Gram-positive and Gram-negative bacteria. Compounds (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Molecular Insights into an Antibiotic Enhancer Action of New Morpholine-Containing 5-Arylideneimidazolones in the Fight against MDR Bacteria. · full record | OpenQuestion